Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver

M Kanematsu1, H Kondo, R C Semelka

  • 1Department of Radiology, Gifu University School of Medicine, Tsukasamachi, Gifu, Japan. masa-gif@umin.ac.jp

Clinical Radiology
|October 3, 2003
PubMed
Abstract

Insights

Early-enhancing, non-neoplastic liver lesions are often caused by arterio-portal shunting. Radiologists should accurately identify these non-malignant findings on MRI to avoid misdiagnosis and unnecessary surgical considerations.

Area of Science:

  • Radiology
  • Hepatology
  • Medical Imaging

Background:

  • Early-enhancing (EN) lesions on liver MRI can be mistaken for malignant tumors.
  • Accurate differentiation of EN lesions is crucial for patient management.

Purpose of the Study:

  • To determine the frequency, causes, and significance of EN lesions on gadolinium-enhanced MRI.
  • To assess the non-neoplastic nature of these lesions in patients suspected of having hepatic tumors.

Main Methods:

  • Review of 125 patients' MRI scans with gadolinium enhancement.
  • Correlation with conventional angiography and CT hepatic arteriography/CT during arterial portography.
  • Surgical or long-term follow-up imaging for definitive diagnosis.

Main Results:

  • 78 EN lesions were identified in 36 patients (29%).
  • Non-neoplastic arterio-portal shunting was the most common cause (62%).
  • Radiologists prospectively diagnosed 44% as probable non-neoplastic lesions.

Conclusions:

  • Non-neoplastic arterio-portal shunting frequently causes EN lesions on liver MRI.
  • Careful interpretation of MRI can ascertain the non-neoplastic nature of these lesions.
  • Avoid overcalling EN lesions as malignant to prevent inappropriate surgical decisions.